Back to Mobile View

medicine

The majority of gold demand these days goes to jewelry and investors, but the precious metal is good for more than looking pretty and providing a hard asset: Industrial and technological uses for gold are growing.
Officially, it's the FDA's job to ensure that pharmaceutical ads adhere to guidelines. But the agency's annual compliance budget is $9 million, while drug companies spend $58 billion a year on marketing. So it comes as no surprise that only 18% of ads are in compliance with the rules. But it's still disturbing: This is your health.
Do you want your new prescription drugs to be made under last century's oversight? Like it or not, that's likely what you're getting -- or worse -- because increasingly, Americans' medicines are made overseas in place where the oversight isn't up to U.S. standards.
Free clinics and the uninsured are paying a heavy price for the nation's teetering recovery: More than half of the clinics are now time turning away eligible patients -- many for the first time -- according to an AmeriCares report published Wednesday.
It's a guarantee in our health-care system: You may get better or you may not, but what you will get either way is paperwork: insurance claims, bills, receipts, and reams of forms that stand between you and the money you're owed. Recently, a new industry has sprung up to help you conquer the paper and recover your cash.
A year after President Obama signed the Patient Protection and Affordable Care Act into law, many Americans are still struggling to get their insurance to cover basic medical treatments. And now, they are increasingly exploring less expensive alternatives to traditional Western medicine -- like acupuncture.
The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in 56 years. It's not terribly effective: It only worked for 35% of the patients tested. But experts say the approval could prompt the development of more effective drugs.
In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world's largest pharmaceutical company announced large research and development cuts were on the way.
Vertex Pharmaceutical shares soared 15% Wednesday as Wall Street cheered the results of a late-stage study of its new cystic fibrosis drug, an experimental treatment that targets the underlying cause of the disease rather than just its symptoms.
Health care providers have been reporting unprecedented shortages of prescription drugs, including vital medications such as chemotherapies and antibiotics. Under current law, the FDA has no power to act, so two senators have introduced a bill to help government get a handle on the problem.

Market Movers

SymbolLastChange / %Volume

Most Actives

BAC
Bank of America Corp
8.10-0.09
-1.04%
149.19M
ALU
Alcatel-Lucent (ADR)
2.20+0.26
+13.40%
94.27M
PBR
Petroleo Brasileiro S.A. (ADR)
29.60-2.39
-7.47%
23.82M
GE
General Electric Company
18.92-0.22
-1.12%
23.49M

% Gainers

CIE
Cobalt International Energy
32.67 +8.77
+36.69%
13.67M
LNKD
LinkedIn Corp.
88.72 +12.33
+16.14%
8.26M
ALU
Alcatel-Lucent (ADR)
2.20 +0.26
+13.40%
94.27M
WNS
WNS (Holdings) Limited (ADR)
10.56 +1.16
+12.34%
2.64M

% Losers

KV-B
K-V Pharmaceutical Co. Class B
2.16-0.47
-17.87%
3,679
KV-A
K V Pharmaceutical Co. Class A
2.17-0.44
-16.86%
1.06M
NBG-A
National Bank of Greece SA (ADR)
5.71-1.04
-15.41%
79,114
OC-B
Owens Corning (Warrant) 'B'
2.27-0.38
-14.34%
12,194
Newswire

Follow Us

Headlines From DailyFinance Partners

CNN Money
CNBC
Smart Money
Consumer Reports
Huffington Post
AOL Energy
AOL Jobs
Business News Personal Finance Investing Our Partners

DailyFinance Sitemap | Terms of Service | Privacy Policy | Trademarks | HELP | Advertise With Us

© Copyright 2012 AOL Inc. All Rights Reserved